Πέμπτη 5 Ιανουαρίου 2017

A serum biomarker may predict response to immunotherapy drugs that target immune checkpoints

Serum levels of ANGPT2, a protein related to angiogenesis (blood vessel formation), was found to predict response to and influence the outcomes of treatment with a class of immunotherapeutics called immune checkpoint inhibitors in patients with advanced...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2jdigYT
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις